New The Lancet Reg Health-Europe - major disparities in use of gFOBT, FIT, and colonoscopy for colorectal cancer screening across European countries

thelancet.com/journals/lanep…

#CRCSM #OncTwitter #GITwitter OncoAlert

April is #BowelCancer Awareness Month 📣

And we are passionate about bringing you the latest news & updates 🎥 🗞️

Aasma Shaukat MD MPH, MD, MPH, discusses the current landscape of #colonoscopyscreening in the US 🇺🇸🔦

Learn more 👉 vjoncology.com/video/_sp7wooh…

#CRCsm

New eClinicalMedicine – The Lancet Discovery Science - Safety & feasibility of chemotherapy followed by liver transplantation for unresectable colorectal liver metastases: insights from the TransMet RCT

thelancet.com/journals/eclin…

#OncTwitter #LiverTwitter OncoAlert #CRCSM

🥁🥁🥁Tweetorial
FOxTROT, the 1st ph 3 RCT of neoadjuvant chemo (NAC) in locally advanced colon cancer
We report that NAC is
✅deliverable and safe
✅led to statistically significant reduction in cancer recurrence than upfront surgery
A 🧵 (1/14)
#crcsm
ascopubs.org/doi/full/10.12…

Check out Dr. Ibrahim Sahin Ibrahim Halil SAHIN, MD UPMC Hillman Cancer Center discussing Early-Onset CRC: A New Epidemic With Knowns and Unknowns

Full 📽️ on #VuMedi
👇
bit.ly/YOCC

#ColorectalCancer AwarenessMonth University of Pittsburgh
#OncEd #gicsm #OncTwitter #oncology #CRCSM #ColorectalCancer

45 is the new 50 when it comes to colorectal cancer screening!

⁦Intermountain Health⁩ ⁦Alta View Hospital⁩ #crcsm

A friend brought over some tulips yesterday for Shannon and I to enjoy.

Unfortunately they’re poisonous to cats, so we have to keep them somewhere unconventional and out of reach.

I always enjoy fresh flowers 💐

#StageIV #ColonCancer #mCRC #CRCSM

NY relentless champions at #CallOnCongress Fight Colorectal Cancer met with relentlessness king Chuck Schumer’s team complete with #BlueForCRC nailfies, #StrongArmSelfies Thank you for a lifetime of support for #crcsm community to get EQUITABLE access to screening, early detection, and treatment

#GISeries : Here we🗣️about the U.S. FDA approval of #Fruquintinib from #FRESCO2 & how it fits in our Rx paradigm w/Arvind Dasari, MD, MS

Full Int:
- targetedonc.com/pivotal-practi…
- oncbrothers.com/JC-FRESCO2
- Also on the “Oncology Brothers” podcast

#OncTwitter #MedTwitter Targeted Oncology #crcsm

🎉 Excited to stay on as Assistant Professor in GI Medical Oncology at MD Anderson Cancer Center after graduation. Immensely grateful to my mentors & the support of my family and friends. Thankful to our patients and looking forward to working together to #EndCancer 🚀 #CRCSM #CCAhope

Dr. Carolina Bernabe presents updates in GI/GU! #crcsm #LEAD23

GI Series: #ColonCancer algorithm, w/ Aparna Raj Parikh to reiterate the current landscape:

Full Discussion:
- cancernetwork.com/treatment-algo…
- Oncbrothers.com/colon-2024
-Also on the “Oncology Brothers” podcast

#OncTwitter CancerNetwork® #MedTwitter #GISM #crcsm

#GI24 ASCO
CHECKMATE 8HW 🫳🎤
dMMR mCRC - nivo + ipi1
Dr Thierry Andre
📌 PFS HR 0.21, p<0.001 ⭐️
📌 2y PFS rate 72% v14%
➡️ No early crossover of the curves! 🙌
➡️ replaces pembro as SOC in 1L dMMR mCRC
OncoAlert #CRCsm

A 8-3
PRIME-RT is an ongoing p2 RCT comparing:
SC-RT + Durva → FOLFOX-Durva
vs.
LC-CRT + Durva → FOLFOX-Durva

❓Can the addition of ICI ⬆️ organ preservation rates by ⬆️clinical complete response
❓Can ICI-RT prime the systemic anti-tumor immune response
#CRCTrialsChat #CRCSM

Sotorasib + Panitumumab improves PFS in pts wir KRAS G12C mut metastatic #colorectalcancer !

No new safety signals.

#crcsm 💙

#ESMO23 OncoAlert 🚨

A 2-8

📌 LARC (cT≥3 or cN+) is heterogeneous!

📌Select patients with upper rectal cancers amenable to sphincter-preserving surgery and no other high risk features may potentially omit radiotherapy and/or systemic therapy
More on this later!
#RectalCancer !
#CRCTrialsChat #CRCSM

Star fellow ⭐️⭐️ Tara Davidson giving an incredible review of the history of KRAS at our first back to in person GIMO journal club #crcsm

A little late….but #gi23 I’m a proud supervisor (again!) Chris Williams presenting data on cd3/cd8 as a prognostic and predictive marker in stage 2 colon cancer (yes that is a merit award you see 🤩).
Keep an eye on this one…. #crcsm

So proud of my mentee Thejus Jayakrishnan, great job presenting our work on metabolomic differences between young-onset and average-onset CRC.
We found:
⚡️Citrate is significantly more abundant in aoCRC
⚡️Arginine biosynthesis and TCA cycle are ⬆️
#ASCO23 #CleClinicCancer #crcsm

#FamilialAdenomatousPolyposis is a rare condition that causes polyps to form in your colon and rectum that are likely to become cancerous. Learn more: mayocl.in/4aQ0Do2 #crcsm Mayo Clinic